BioNTech’s ‘extensive’ cancer pipeline comes into focus, with emphasis on ADCsnews2023-11-08T16:13:59+00:00November 8th, 2023|Endpoints News|
Pyxis Oncology lays off 20 employees; Xencor’s royalty sale to a pension plan; Jazz partners with MD Andersonnews2023-11-08T16:13:30+00:00November 8th, 2023|Endpoints News|
Sheryl Sandberg-backed AI data platform launches to personalize fertility carenews2023-11-08T15:09:27+00:00November 8th, 2023|Endpoints News|
Biogen CEO seeks collaborations to expand pipeline as postpartum depression, Alzheimer’s and ALS drugs launchnews2023-11-08T12:25:52+00:00November 8th, 2023|Endpoints News|
Forward Therapeutics, the first biotech from Curie.Bio, raises $50M for oral small molecules in immunologynews2023-11-08T12:00:15+00:00November 8th, 2023|Endpoints News|
Amazon Prime members can now get One Medical membership at a discountnews2023-11-08T12:00:02+00:00November 8th, 2023|Endpoints News|
Gilead’s revenues ‘flat’ for Q3 and ‘relatively unexciting,’ excluding remdesivir salesnews2023-11-08T11:55:49+00:00November 8th, 2023|Endpoints News|
Bit.bio finally details cell therapy pipeline for regenerative treatment, with initial focus on livernews2023-11-08T08:00:57+00:00November 8th, 2023|Endpoints News|
Flagship Pioneering takes another big step across the globe, planting its biotech flag in Asianews2023-11-07T22:00:28+00:00November 7th, 2023|Endpoints News|
Activist investor Elliott buys $1B+ stake in BioMarin as CEO change nearsnews2023-11-07T19:32:36+00:00November 7th, 2023|Endpoints News|
